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INTRODUCTION:  Chylothorax  is a very  rare  complication  of chronic  lymphocytic  leukemia.
PRESENTATION OF  CASE:  We  describe  the  case  of  an  83-year  old  woman  with chronic  lymphocytic
leukemia,  complicated  by  recurrent  chylothorax  and  ultimately  treated  by  pleurodesis  with  bleomycin.
DISCUSSION: There  are  several  options  for management  of patients  presenting  with  chylothorax  due toccepted  18 December 2011
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CONCLUSION: Pleurodesis  is  a reasonable  and  effective  treatment  modality  for  patients  with  refractory
chylothorax.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. 
effective, as chyle production gradually diminished from about
1000 ml  daily for the ﬁrst 3 days of treatment to about 100 ml/day
after ten days of starting treatment. Thereafter we started oral feed-
ing of the patient ﬁrst on a medium chain triglyceride diet for few
Open access under CC BY-NC-ND license. leurodesis
. Introduction
Chylothorax or the presence of chyle in the pleural cavity is most
ommonly the result of neoplastic diseases, with lymphoma being
he leading cause, followed by lung cancer, and is also encountered
s a postoperative complication in operations involving the aorta
r esophagus.1 Chylothorax is only rarely reported as the result of
hronic lymphocytic leukemia (CLL), with only a few cases reported
n the literature.2,3 We  describe the case of a 83-year old woman
ith chronic lymphocytic leukemia complicated by recurrent chy-
othorax and ultimately treated by pleurodesis.
. Case presentation
The  patient presented to the emergency department with grad-
ally worsening dyspnea of few days duration. She had been
iagnosed with chronic lymphocytic leukemia 2 years ago. The
hest X-ray revealed a large effusion into the right pleural cavity
Fig. 1). Chest CT scan showed no mediastinal adenopathy (Fig. 2).
he had no fever and she mentioned no night sweats, chest pain,
ough and pleuritic pain.
Tuberculin  test was negative and she did not mention travel-
ing abroad recently. On thoracentesis the ﬂuid was  milky with
riglyceride and cholesterol levels at 1168 and 143 mg/dl respec-
ively and the diagnosis of chylothorax was made. Lymphocytes
ere predominant at the pleural ﬂuid.
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E-mail address: gphilippakis@hotmail.gr (G.E. Philippakis).
210-2612 ©   2012 Surgical Associates Ltd. Published by Elsevier Ltd. 
oi:10.1016/j.ijscr.2011.12.008
Open access under CC BYA chest tube was inserted and about 1500 ml  of milky ﬂuid was
drained. Consequently the patient was given nothing by mouth and
started on total parenteral nutrition. Chemotherapy or mediastinal
irradiation options were not offered to the patient, because she
had no mediastinal adenopathy and also she was very debilitated.
Conservative treatment with nothing per os and TPN was reallyFig. 1. A large right pleural effusion is obvious in chest X-ray.
-NC-ND license. 
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were no local complications related to the use of bleomycin. On
routine follow-up with chest X-ray every 15 days for the following
six months there was  no recurrence of chylothorax (Fig. 3) (noteFig. 2. Chest CT scan. No m
ays with subsequent switch to a full diet. There was no increase
n the amount of chyle after several days of feeding, at which point
he chest tube was removed and the patient was discharged home.
nfortunately, the chylothorax recurred after about two weeks. A
hest tube was inserted and a trial of conservative treatment was
ried again, but with no results at this time. Daily production of
hyle was over 500 ml  per day. After about ten days of unsuccess-
ul treatment, the patient was discharged home with a Heimlich
alve connected to the chest tube (we connected the Heimlich valve
o a urinary bag, to which we made a small opening to its upper
orner by scissors, so that to avoid potential air entrapment) with
nstructions for a medium chain triglyceride diet and weekly clini-
al and laboratory examinations on an outpatient basis, as well as
aily measurement and recording of chyle production. The patient
nd her relatives were also instructed to contact us, whenever they
oticed abrupt discontinuation of ﬂuid production or shortness of
reath, because these facts might be related to chest tube blockage
r fever as evidence of infectious complications related to the chest
ube. The patient had a daily production of chyle between 500 and
000 ml  per day at home. One month later on telephone conver-
ation we were told that the previous 24-h chyle production was
nly 100 ml.  The patient was instructed to come immediately to the
ospital for examination. Chest X-ray showed a very small pleural
ffusion, so we decided to perform pleurodesis with bleomycin,
y instilling four ampoules of bleomycin through the chest tube
nto the right pleural cavity and then clamping the tube for sev-
ral hours. We  removed the chest tube the following day. Theretinal adenopathy is noted.Fig. 3. Chest X-ray performed at routine follow-up. Note bilateral pleural effusions,
but  no recurrence of chylothorax. The patient was subjected to thoracentesis, which
revealed clear, serous ﬂuid.
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here are bilateral pleural effusions in chest X-ray performed about
 months later. The patient was subjected to thoracentesis, which
evealed clear, serous ﬂuid).
. Discussion
Although CLL is often associated with pleural effusion,4 chy-
othorax from CLL is rare, with only few cases identiﬁed in the
iterature. Malignancies cause chylothorax through disruption or
ompression of the thoracic duct from mediastinal adenopathy
r mass effect of the tumor itself. CLL causes diffuse adenopa-
hy but rarely causes mediastinal adenopathy signiﬁcant enough
o obstruct the thoracic duct,2 which probably explains the rar-
ty of chylothorax as a manifestation of that disease entity. The
echanism of how CLL causes chylothorax is not fully eluci-
ated. There exist a few theories to explain how CLL may  result
n chylothorax. The most common mode is the classic way in
hich a malignancy in general causes chylothorax, that is through
ediastinal adenopathy, as we mentioned above. Another model,
robably most suitable and speciﬁc for CLL-induced chylothorax,
nvolves the ﬂow of leukemic lymphocytes through the lym-
hatic system. The presence of an extremely large number of
bnormal lymphocytes in CLL may  cause cell clustering in the lym-
hatic system. This sludging may  result in obstruction of either
he thoracic duct or lymphatics draining the pleura, resulting in
 chylothorax.3 That model suits perfectly in our case, because
o enlarged mediastinal lymph nodes were evident on chest
T scan.
Initial management of chylothorax due to CLL may be generally
onservative, as is true with most cases of chylothorax due to vari-
us causes, with patients being given nothing by mouth and started
n total parenteral nutrition. If the chylothorax does not resolve
fter about two weeks of conservative treatment, and depending
n the amount of chyle produced, more aggressive measures have
o be taken. If enlarged mediastinal lymph nodes are present, either
hemotherapy or radiotherapy,5 or both can be offered as a treat-
ent option.
In addition medical thoracoscopic pleurodesis of the pleu-
al space can be tried as a therapeutic measure to resolve the
hylothorax.6 In cases not responding to the measures mentioned
bove, surgery can be performed to ligate the thoracic duct,7 via a
ight thoracotomy incision or thoracoscopically.
In the case we present, treatment options were quite limited,
ecause of the poor general condition of the patient. We  resorted
n the solution of Heimlich valve, after the recurrence of chylotho-
ax and the unsuccessful second course of conservative treatment.
hat is not an ideal treatment strategy, because the patient loses
lbumin, proteins and other nutrients through the chyle, result-
ng in an impaired immune and nutritional status. It seems that
ur instructions to the patient for medium-chain triglyceride diet
eaded to a marked diminution of daily chyle production, rendering
s able to perform pleurodesis at a favorable time point, with the
ope that creation of adhesions into the right pleural cavity might
lose the “ﬁstulous” connection of the thoracic duct with the right
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pleural cavity. We  judged that favorable conditions for perform-
ing pleurodesis existed, that is the lung to be fully expanded and
daily production of pleural ﬂuid to be negligible, so we decided to
proceed to pleurodesis.
We are not aware of any other case of refractory CLL-induced
chylothorax treated successfully by simple pleurodesis.
4. Conclusion
CLL-induced chylothorax is quite rare, so little clinical evi-
dence exists to guide the clinician in determining which treatment
modality is best for these patients. Mediastinal irradiation (even
in the absence of mediastinal adenopathy), mediastinal irradia-
tion followed by talc pleurodesis, and thoracic duct ligation with
or without pleurodesis may  all be reasonable options for the
treatment of CLL-induced chylothorax.2,3,7 In the case we present
pleurodesis was  successful without use of other modalities. There
seemed to be no other deﬁnite solution to the problem of that
debilitated patient than to try a pleurodesis when circumstances
allowed.
Conﬂict of interest
None.
Funding
None.
Ethical approval
Written informed consent was obtained from the patient for
publication of this case report and accompanying images.
Author’s contribution
G. Philippakis and M.  Moustardas involved in study design, data
analysis and writing the manuscript and G.  Philippakis helped in
data collections.
References
. Light RW.  Chylothorax and pseudochylothorax. In: Pleural diseases. 4th ed.
Philadelphia: Lippincott Williams & Wilkins; 2001. p. 327–43.
.  Zimhony O, Davidovitch Y, Shtalrid M. Chronic lymphocytic leukaemia compli-
cated by chylothorax. J Intern Med  1994;235:375–7.
. Rice TW,  Milstone AP. Chylothorax as a result of chronic lymphocytic leukemia:
case report and review of the literature. South Med  J 2004;97(March (3)):291–4.
.  Jenkins PF, Ward MJ,  Davies P, Fletcher J. Non-Hodgkin’s lymphoma, chronic lym-
phatic leukaemia and the lung. Br J Dis Chest 1981;75:22–30.
.  Bruneau R, Rubin P. The management of pleural effusions and chylothorax in
lymphoma. Radiology 1965;85:1085–92.
.  Mares DC, Mathur PN. Medical thoracoscopic talc pleurodesis for chylothorax due
to  lymphoma: a case series. Chest 1998;114:731–5.
.  Fahimi H, Casselman FP, Mariani MA,  van Boven WJ,  Knaepen PJ, van Swieten
HA,  et al. Current management of postoperative chylothorax. Ann Thorac Surg
2001;71:448–51.
uted under the IJSCR Supplemental terms and conditions,  which
ion in any medium, provided the original authors and source are
